Financing the future of care: Capital strategies for precision medicine in value-based care
Precision medicine is delivering measurable performance in value-based care, but the returns often lag the costs.
This whitepaper lays out how health system executives and value-based care leaders can advance the clinical and financial benefits of precision medicine. It details how to fund precision medicine and AI in a way that matches reimbursement timing and risk, allowing organizations to scale what works without straining cash flow.
Real-world results anchor the guidance.
Case studies include:
This whitepaper lays out how health system executives and value-based care leaders can advance the clinical and financial benefits of precision medicine. It details how to fund precision medicine and AI in a way that matches reimbursement timing and risk, allowing organizations to scale what works without straining cash flow.
Real-world results anchor the guidance.
Case studies include:
- How Cleveland Clinic's AI-supported precision health program for diabetes improved control and reduced avoidable acute care.
- How a leader in value-based, integrated healthcare cut emergency department visits by 34% and reduced total cost of care by 20-30% across Medicaid and Medicare populations.
- How a 500-bed health system saw coder productivity rise 62%, denials drop 35%, and A/R days fall from 52 to 38 in under nine months, yielding full ROI in under 9 months.
Please fill out the form to download the whitepaper.